Harnessing Your Immune System’s Hidden Powers to Fight Cancer
Cancer can be a stubborn adversary.
For years, doctors have been desperately trying to fine-tune treatments to help your body’s natural defenses fight back against this illness.
But what if your immune system has an untapped superpower that could boost cancer survival even more? It turns out, the answer might have been hiding in plain sight, in a type of immune response that was previously misunderstood…
You’ve likely heard of immunotherapy. It’s a treatment that uses your very own immune system to target and destroy cancer cells.
In particular, CAR-T cell therapy—which involves removing T cells from the body, supercharging them to attack cancer, and then reintroducing them— has made headlines for treating blood cancers like leukemia.
But while some patients experience long-term remission, others relapse soon after treatment, leaving researchers searching for a solution.
Well, new research might have uncovered one: a secondary immune response.
Previously believed to help cancer grow, this type of response—called a type 2 immune response—was dismissed for years.
But studies are now showing that when combined with the type 1 response that normally fights cancer, it could be the key to longer-lasting remission.
See, the traditional belief was that type 1 immunity was the body’s go-to cancer-fighting response. It targets internal threats like viruses and cancers, while type 2 immunity was thought to tackle larger external parasites, like worms.
However, a breakthrough study led by a team at EPFL revealed something surprising: survivors of CAR-T cell therapy who remained cancer-free for years had markers indicating type 2 immune activity.
This discovery challenges the old narrative that type 2 responses don’t play a role in fighting cancer. In fact, they might be essential.
In a follow-up study, scientists tested this idea on mice with colon cancer, using either type 1 immune response alone or a combination of type 1 and type 2 responses. And the results were staggering…
In the combined group, 86 percent of the mice were cured, compared to none in the type 1-only group. Even more encouraging, when these cured mice were reintroduced to cancer months later, their immune systems fought it off with ease!
This finding could revolutionize immunotherapy treatments. It suggests that by using a “one-two punch” of both immune responses, we might dramatically improve cancer survival rates, even for cancers that are notoriously tough to treat, like solid tumors.
The combination of immune responses seems to work by supercharging T cells, giving them an energy boost through a process called glycolysis. This allows the cells to continue fighting cancer for longer, rather than becoming exhausted.
By adding this overlooked response to cancer immunotherapy, researchers believe they can unlock a new level of synergy in treatment—what one of the study’s co-authors calls the “yin and yang” of immunity. This balance could be the key to developing next-generation treatments that not only kill cancer cells but keep them from coming back.
While this research is still in its early stages, the results are promising. The combination of type 1 and type 2 immunity could be the future of cancer treatment, offering hope to patients facing cancers that don’t respond to current immunotherapies.
If you’re looking for more natural, innovative cancer-fighting strategies, don’t miss The Health Sciences Institute’s “Beyond Chemotherapy” Cancer Protocol. This comprehensive guide offers a treasure trove of natural treatments—used successfully around the world—that go far beyond the standard care offered by mainstream oncologists. Discover safe, powerful solutions, including natural remedies that can boost your body’s defenses and even improve cancer treatment outcomes—click here for more information.
Here’s to fighting smarter, not harder,
Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team
Sources:
Irving, M., & Staff, S. (2024, October 2). Immune Response Thought to Aid Cancer Could Be an Unexpected Cure. ScienceAlert. https://www.sciencealert.com/immune-response-thought-to-aid-cancer-could-be-an-unexpected-cure
